Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Microbiome Therapeutics Market 2022-2028
... overcome the limitation of conventional therapeutics by providing personalized, harmonized, reliable, and sustainable treatment. Its huge economic potential has been shown in the global therapeutics market. According to market research study published by Gen Consulting ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
Cell Line Development Market Size, Share and Industry Analysis Report by Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope, Electroporators, FACS}, Accessories & Consumables), by Source (Mammalian, Non-mammalian {Insects, Amphibians}), by Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), by Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
... Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), by Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028 The cell line development ... Read More
-
Global Chronic Eosinophilic Leukemia Market - 2022-2029
... a CAGR of XX% during the forecast period (2022-2029). Chronic eosinophilic leukemia is a subtype of clonal eosinophilia caused by a new genetic mutation or change in blood cells. It is also known as a ... Read More
-
Global Anti-Hypertension Drugs Market - 2022-2029
... CAGR of XX% during the forecast period (2022-2029). Hypertension is a long-term medical condition that is marked by the high pressure of blood in the arteries, which is persistently elevated. Anti-hypertensive is used for the ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Psoriasis Global Market Report 2022
... it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected ... Read More
-
2022 Global Forecast for Osteoarthritis Therapeutics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases; Global Summary 2021: Covid 19 Impact and Recovery
... 2020 at a CAGR of 7.33%. The global dermatology drugs market is expected to grow from $37.57 billion in 2020 to $62.82 billion in 2025 at a CAGR of 10.82%. Dermatology Drugs Market Covering Acne; ... Read More
-
Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it ... Read More
-
Middle East and Africa Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in MEA ... Read More
-
North America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in North America is expected to grow from US$ 2,136.41 million in 2021 to US$ 7,024.71 million by ... Read More
-
South America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in South America is expected to grow from US$ 319.10 million in 2021 to US$ 1,003.03 million by ... Read More
-
Asia Pacific Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Asia Pacific is expected to grow from US$ 1,051.58 million in 2021 to US$ 3,557.63 million by ... Read More
-
Europe Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in Europe is expected to ... Read More
-
South America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in SAM is expected ... Read More
-
North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in North America is ... Read More
-
Colombia, Chile and Peru Wilson’s Disease Treatment Market, by Drugs (D-Penicillamine, Trientine, and Zinc Acetate), by Distribution Channel (Hospital Pharmacies and Government Distribution Channels), and by Country (Colombia, Chile, and Peru) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Opportunity Analysis, 2022 - 2030 Wilson’s disease is a rare genetic disorder characterized by excess copper stored in various body tissues, particularly in the liver, brain, and corneas of the eyes. The body needs ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... ganglioside GD2 is a major focus of drug developers. There are 131 drugs in the pipeline with 98% molecules present in early-to-mid stage. Mid-sized Pharma dominates clinical development in this space. More frequent use of ... Read More
-
Metabolomics Market by Product and Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools & Service), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), and Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030
... Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030 Metabolomics is study and analysis of biochemical processes involving intermediates and products of metabolic activity. The products are called as metabolomes that ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
... 90% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The rising prevalence and more frequent use of newer symptomatic treatments are expected to drive the market. However, the market growth is ... Read More
-
Healthcare Artificial Intelligence (AI) Market Forecasts to 2028 – Global Analysis By Technology (Deep Learning, Machine), Application (Drug Discovery, Fraud Detection), End User (Research Laboratories, Hospital) and By Geography
... Healthcare Artificial Intelligence (AI) Market is accounted for $6.66 billion in 2021 and is expected to reach $86.37 billion by 2028 growing at a CAGR of 44.2% during the forecast period. Artificial intelligence was initiated ... Read More
-
Gastrointestinal Drugs Global Market Report 2022
... and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with Covid 19 as they are ... Read More
-
Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028 Global Parkinson’s Disease Treatment Market is valued approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2022
... assess the global antisense & RNAi therapeutics market. This report focuses on antisense & RNAi therapeutics market which is experiencing strong growth. The report gives a guide to the antisense & RNAi therapeutics market which ... Read More
Research Assistance
